CHORUS AVIATION INC (CHR-DB-B.CA) Stock Fundamental Analysis
TSX:CHR-DB-B - Toronto Stock Exchange - CA17040TAE25 - Currency: CAD
We assign a fundamental rating of 3 out of 10 to CHR-DB-B. CHR-DB-B was compared to 9 industry peers in the Passenger Airlines industry. Both the profitability and the financial health of CHR-DB-B get a neutral evaluation. Nothing too spectacular is happening here. CHR-DB-B is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year CHR-DB-B was profitable.
In the past year CHR-DB-B had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: CHR-DB-B reported negative net income in multiple years.
Each year in the past 5 years CHR-DB-B had a positive operating cash flow.
1.2 Ratios
With a Return On Assets value of -17.42%, CHR-DB-B is not doing good in the industry: 77.78% of the companies in the same industry are doing better.
The Return On Equity of CHR-DB-B (-47.80%) is worse than 66.67% of its industry peers.
The Return On Invested Capital of CHR-DB-B (6.29%) is better than 77.78% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CHR-DB-B is in line with the industry average of 5.85%.
The 3 year average ROIC (5.30%) for CHR-DB-B is below the current ROIC(6.29%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -17.42% | ||
| ROE | -47.8% | ||
| ROIC | 6.29% |
ROA(3y)-4.73%
ROA(5y)-2.72%
ROE(3y)-14.73%
ROE(5y)-8.13%
ROIC(3y)5.3%
ROIC(5y)4.78%
1.3 Margins
CHR-DB-B has a Operating Margin (6.77%) which is in line with its industry peers.
In the last couple of years the Operating Margin of CHR-DB-B has declined.
The Gross Margin of CHR-DB-B (65.04%) is better than 77.78% of its industry peers.
CHR-DB-B's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.77% | ||
| PM (TTM) | N/A | ||
| GM | 65.04% |
OM growth 3Y-18.7%
OM growth 5Y-14.78%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.38%
GM growth 5Y-2.24%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CHR-DB-B is destroying value.
Compared to 1 year ago, CHR-DB-B has less shares outstanding
Compared to 5 years ago, CHR-DB-B has more shares outstanding
CHR-DB-B has a better debt/assets ratio than last year.
2.2 Solvency
CHR-DB-B has an Altman-Z score of 2.24. This is not the best score and indicates that CHR-DB-B is in the grey zone with still only limited risk for bankruptcy at the moment.
The Altman-Z score of CHR-DB-B (2.24) is better than 100.00% of its industry peers.
CHR-DB-B has a debt to FCF ratio of 3.86. This is a good value and a sign of high solvency as CHR-DB-B would need 3.86 years to pay back of all of its debts.
CHR-DB-B has a better Debt to FCF ratio (3.86) than 77.78% of its industry peers.
A Debt/Equity ratio of 0.68 indicates that CHR-DB-B is somewhat dependend on debt financing.
CHR-DB-B has a better Debt to Equity ratio (0.68) than 66.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.68 | ||
| Debt/FCF | 3.86 | ||
| Altman-Z | 2.24 |
ROIC/WACC0.79
WACC8.01%
2.3 Liquidity
CHR-DB-B has a Current Ratio of 1.22. This is a normal value and indicates that CHR-DB-B is financially healthy and should not expect problems in meeting its short term obligations.
CHR-DB-B has a Current ratio (1.22) which is in line with its industry peers.
A Quick Ratio of 0.71 indicates that CHR-DB-B may have some problems paying its short term obligations.
CHR-DB-B has a worse Quick ratio (0.71) than 66.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.22 | ||
| Quick Ratio | 0.71 |
3. Growth
3.1 Past
The earnings per share for CHR-DB-B have decreased by -5.14% in the last year.
The earnings per share for CHR-DB-B have been decreasing by -19.03% on average. This is quite bad
The Revenue for CHR-DB-B has decreased by -14.15% in the past year. This is quite bad
Measured over the past years, CHR-DB-B shows a small growth in Revenue. The Revenue has been growing by 0.56% on average per year.
EPS 1Y (TTM)-5.14%
EPS 3Y-16.46%
EPS 5Y-19.03%
EPS Q2Q%35.71%
Revenue 1Y (TTM)-14.15%
Revenue growth 3Y11.15%
Revenue growth 5Y0.56%
Sales Q2Q%-18.31%
3.2 Future
CHR-DB-B is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 5.59% yearly.
Based on estimates for the next years, CHR-DB-B will show a small growth in Revenue. The Revenue will grow by 0.78% on average per year.
EPS Next Y52.62%
EPS Next 2Y12.88%
EPS Next 3Y5.59%
EPS Next 5YN/A
Revenue Next Year-2.29%
Revenue Next 2Y-2.03%
Revenue Next 3Y0.78%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 60.40, CHR-DB-B can be considered very expensive at the moment.
Based on the Price/Earnings ratio, CHR-DB-B is valued a bit more expensive than 66.67% of the companies in the same industry.
When comparing the Price/Earnings ratio of CHR-DB-B to the average of the S&P500 Index (25.82), we can say CHR-DB-B is valued expensively.
A Price/Forward Earnings ratio of 52.11 indicates a quite expensive valuation of CHR-DB-B.
66.67% of the companies in the same industry are cheaper than CHR-DB-B, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of CHR-DB-B to the average of the S&P500 Index (21.76), we can say CHR-DB-B is valued expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 60.4 | ||
| Fwd PE | 52.11 |
4.2 Price Multiples
CHR-DB-B's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. CHR-DB-B is more expensive than 77.78% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CHR-DB-B is on the same level as its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 24.45 | ||
| EV/EBITDA | 16.33 |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.15
PEG (5Y)N/A
EPS Next 2Y12.88%
EPS Next 3Y5.59%
5. Dividend
5.1 Amount
No dividends for CHR-DB-B!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
TSX:CHR-DB-B (5/22/2025, 7:00:00 PM)
100.26
-0.34 (-0.34%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryPassenger Airlines
Earnings (Last)
Earnings (Next)
Inst Owners1.95%
Inst Owner ChangeN/A
Ins Owners1.18%
Ins Owner ChangeN/A
Market Cap2.65B
Analysts78.18
Price Target133.9 (33.55%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend0.98
Dividend Growth(5Y)21.58%
DP-7.29%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)14.69%
Min EPS beat(2)3.87%
Max EPS beat(2)25.51%
EPS beat(4)3
Avg EPS beat(4)39.29%
Min EPS beat(4)-80.2%
Max EPS beat(4)207.96%
EPS beat(8)4
Avg EPS beat(8)7.83%
EPS beat(12)5
Avg EPS beat(12)1.78%
EPS beat(16)7
Avg EPS beat(16)0.15%
Revenue beat(2)0
Avg Revenue beat(2)-3.86%
Min Revenue beat(2)-3.95%
Max Revenue beat(2)-3.78%
Revenue beat(4)0
Avg Revenue beat(4)-6.49%
Min Revenue beat(4)-10.27%
Max Revenue beat(4)-3.78%
Revenue beat(8)3
Avg Revenue beat(8)-1.85%
Revenue beat(12)5
Avg Revenue beat(12)-1.08%
Revenue beat(16)9
Avg Revenue beat(16)6.44%
PT rev (1m)0%
PT rev (3m)-0.96%
EPS NQ rev (1m)8.33%
EPS NQ rev (3m)715.49%
EPS NY rev (1m)2.32%
EPS NY rev (3m)7.12%
Revenue NQ rev (1m)0.15%
Revenue NQ rev (3m)-0.04%
Revenue NY rev (1m)-0.49%
Revenue NY rev (3m)-0.98%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 60.4 | ||
| Fwd PE | 52.11 | ||
| P/S | 1.9 | ||
| P/FCF | 24.45 | ||
| P/OCF | 17.75 | ||
| P/B | 5.14 | ||
| P/tB | 5.23 | ||
| EV/EBITDA | 16.33 |
EPS(TTM)1.66
EY1.66%
EPS(NY)1.92
Fwd EY1.92%
FCF(TTM)4.1
FCFY4.09%
OCF(TTM)5.65
OCFY5.63%
SpS52.7
BVpS19.51
TBVpS19.18
PEG (NY)1.15
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -17.42% | ||
| ROE | -47.8% | ||
| ROCE | 8.48% | ||
| ROIC | 6.29% | ||
| ROICexc | 6.74% | ||
| ROICexgc | 6.8% | ||
| OM | 6.77% | ||
| PM (TTM) | N/A | ||
| GM | 65.04% | ||
| FCFM | 7.78% |
ROA(3y)-4.73%
ROA(5y)-2.72%
ROE(3y)-14.73%
ROE(5y)-8.13%
ROIC(3y)5.3%
ROIC(5y)4.78%
ROICexc(3y)5.99%
ROICexc(5y)5.28%
ROICexgc(3y)6.05%
ROICexgc(5y)5.32%
ROCE(3y)7.14%
ROCE(5y)6.44%
ROICexcg growth 3Y33.52%
ROICexcg growth 5Y7.31%
ROICexc growth 3Y33.18%
ROICexc growth 5Y7.15%
OM growth 3Y-18.7%
OM growth 5Y-14.78%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.38%
GM growth 5Y-2.24%
F-Score6
Asset Turnover0.98
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.68 | ||
| Debt/FCF | 3.86 | ||
| Debt/EBITDA | 1.9 | ||
| Cap/Depr | 45.9% | ||
| Cap/Sales | 2.93% | ||
| Interest Coverage | 1.46 | ||
| Cash Conversion | 81.41% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.22 | ||
| Quick Ratio | 0.71 | ||
| Altman-Z | 2.24 |
F-Score6
WACC8.01%
ROIC/WACC0.79
Cap/Depr(3y)31.44%
Cap/Depr(5y)62.49%
Cap/Sales(3y)3.58%
Cap/Sales(5y)12.17%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-5.14%
EPS 3Y-16.46%
EPS 5Y-19.03%
EPS Q2Q%35.71%
EPS Next Y52.62%
EPS Next 2Y12.88%
EPS Next 3Y5.59%
EPS Next 5YN/A
Revenue 1Y (TTM)-14.15%
Revenue growth 3Y11.15%
Revenue growth 5Y0.56%
Sales Q2Q%-18.31%
Revenue Next Year-2.29%
Revenue Next 2Y-2.03%
Revenue Next 3Y0.78%
Revenue Next 5YN/A
EBIT growth 1Y-59.15%
EBIT growth 3Y-9.64%
EBIT growth 5Y-14.31%
EBIT Next Year88.24%
EBIT Next 3Y15.21%
EBIT Next 5YN/A
FCF growth 1Y-55.84%
FCF growth 3Y24.37%
FCF growth 5YN/A
OCF growth 1Y-51.04%
OCF growth 3Y12.73%
OCF growth 5Y0.25%